1,3-Di-tert-butyl-4,6-dichloro-1H-pyrazolo[3,4-b]pyridine

Catalog No.: 
ACFZXT508
CAS No.: 
2060049-60-5
Molecular Formula: 
C14H19Cl2N3
Molecular Weight: 
300.23
1,3-Di-tert-butyl-4,6-dichloro-1H-pyrazolo[3,4-b]pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$173.00InquiryInquiry
1g95%$500.00InquiryInquiry
5g95%$2450.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1,3-Di-tert-butyl-4,6-dichloro-1H-pyrazolo[3,4-b]pyridine
IUPAC Name1,3-di-tert-butyl-4,6-dichloro-1H-pyrazolo[3,4-b]pyridine
MDL No.MFCD30477284
Molecular FormulaC14H19Cl2N3
Molecular Weight300.23
SMILESClC1=CC(Cl)=C2C(N(C(C)(C)C)N=C2C(C)(C)C)=N1
InChI KeyOLLBJSRHDSGVCS-UHFFFAOYSA-N
Synonym1H-Pyrazolo[3,4-b]pyridine, 4,6-dichloro-1,3-bis(1,1-dimethylethyl)-
CAS No.2060049-60-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACFZXT508 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFZXT508 route product structure diagram
    ACFZXT5082060049-60-5
Inquiry

2. ACFZXT508 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFZXT508 route product structure diagram
    ACFZXT5082060049-60-5
Inquiry

3. ACFZXT508 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFZXT508 route product structure diagram
    ACFZXT5082060049-60-5
Inquiry

Comments (0)